271 related articles for article (PubMed ID: 24978711)
1. Overexpression of hypoxia-inducible factor-1α is a predictor of poor prognosis in cervical cancer: a clinicopathologic study and a meta-analysis.
Huang M; Chen Q; Xiao J; Yao T; Bian L; Liu C; Lin Z
Int J Gynecol Cancer; 2014 Jul; 24(6):1054-64. PubMed ID: 24978711
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: a meta-analysis.
Ye LY; Zhang Q; Bai XL; Pankaj P; Hu QD; Liang TB
Pancreatology; 2014; 14(5):391-7. PubMed ID: 25278309
[TBL] [Abstract][Full Text] [Related]
4. Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy.
Burri P; Djonov V; Aebersold DM; Lindel K; Studer U; Altermatt HJ; Mazzucchelli L; Greiner RH; Gruber G
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):494-501. PubMed ID: 12738326
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.
Bachtiary B; Schindl M; Pötter R; Dreier B; Knocke TH; Hainfellner JA; Horvat R; Birner P
Clin Cancer Res; 2003 Jun; 9(6):2234-40. PubMed ID: 12796391
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in patients with bone tumor: a systematic review and meta-analysis.
Luo D; Ren H; Zhang W; Xian H; Lian K; Liu H
J Orthop Surg Res; 2019 Feb; 14(1):56. PubMed ID: 30782196
[TBL] [Abstract][Full Text] [Related]
9. Pulsatility Index and Hypoxia Inducible Factor-1α Expression Predict the Clinical Response after External Radiation in Patients with Stage IIB to IVA Cervical Cancer.
Winata IGS; Hidayat YM; Winarno GN; Suardi D; Soetopo S; Suwiyoga K
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2073-2078. PubMed ID: 31350968
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells.
Bai H; Ge S; Lu J; Qian G; Xu R
J Obstet Gynaecol Res; 2013 Feb; 39(2):555-63. PubMed ID: 22925504
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer.
Birner P; Schindl M; Obermair A; Plank C; Breitenecker G; Oberhuber G
Cancer Res; 2000 Sep; 60(17):4693-6. PubMed ID: 10987269
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis.
Zhou J; Huang S; Wang L; Yuan X; Dong Q; Zhang D; Wang X
World J Surg Oncol; 2017 May; 15(1):104. PubMed ID: 28521842
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor 1 alpha (HIF-1α) as a prognostic indicator in patients with gastric tumors: a meta-analysis.
Zhang ZG; Zhang QN; Wang XH; Tian JH
Asian Pac J Cancer Prev; 2013; 14(7):4195-8. PubMed ID: 23991975
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of thymosin β4, vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)-1α in early-stage cervical cancers.
Kim NS; Kang YJ; Jo JO; Kim HY; Oh YR; Kim YO; Jung MH; Ock MS; Cha HJ
Pathol Oncol Res; 2011 Sep; 17(3):493-502. PubMed ID: 21213129
[TBL] [Abstract][Full Text] [Related]
16. Expression of HIF-1α in medullary thyroid cancer identifies a subgroup with poor prognosis.
Lodewijk L; van Diest P; van der Groep P; Ter Hoeve N; Schepers A; Morreau J; Bonenkamp J; van Engen-van Grunsven A; Kruijff S; van Hemel B; Links T; Nieveen van Dijkum E; van Eeden S; Valk G; Borel Rinkes I; Vriens M
Oncotarget; 2017 Apr; 8(17):28650-28659. PubMed ID: 28404916
[TBL] [Abstract][Full Text] [Related]
17. HIF-1 alpha overexpression correlates with poor overall survival and disease-free survival in gastric cancer patients post-gastrectomy.
Chen L; Shi Y; Yuan J; Han Y; Qin R; Wu Q; Jia B; Wei B; Wei L; Dai G; Jiao S
PLoS One; 2014; 9(3):e90678. PubMed ID: 24614305
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
[TBL] [Abstract][Full Text] [Related]
19. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Gruber G; Greiner RH; Hlushchuk R; Aebersold DM; Altermatt HJ; Berclaz G; Djonov V
Breast Cancer Res; 2004; 6(3):R191-8. PubMed ID: 15084243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]